These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9450109)

  • 1. Inhibition of lipoprotein lipase activity by tetrahydrolipstatin.
    Lobo LI; Wilton DC
    Biochem Soc Trans; 1997 Nov; 25(4):S682. PubMed ID: 9450109
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions of lipoprotein lipase with the active-site inhibitor tetrahydrolipstatin (Orlistat).
    Lookene A; Skottova N; Olivecrona G
    Eur J Biochem; 1994 Jun; 222(2):395-403. PubMed ID: 8020477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinetics of heparin inhibition of the esterase and basal lipase activities of lipoprotein lipase.
    Posner I; Desanctis J
    Arch Biochem Biophys; 1987 Mar; 253(2):475-85. PubMed ID: 3566288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin.
    Hadváry P; Lengsfeld H; Wolfer H
    Biochem J; 1988 Dec; 256(2):357-61. PubMed ID: 3223916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lipases from Chromobacterium viscosum and Rhizopus oryzae by tetrahydrolipstatin.
    Potthoff AP; Haalck L; Spener F
    Biochim Biophys Acta; 1998 Jan; 1389(2):123-31. PubMed ID: 9461253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of plasma triglycerides with correction for free glycerol by orlistat inhibition of lipoprotein lipase activity.
    Nagaraju R; Joshi AK; Rajini PS
    Anal Biochem; 2013 Aug; 439(1):44-6. PubMed ID: 23597845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human and rat lipoprotein lipase by high-density lipoprotein.
    Jones SM; Younan SI; Graham A; Rogers MP
    Biochim Biophys Acta; 1986 Sep; 878(2):250-7. PubMed ID: 3756195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lipoprotein lipase by benzene boronic acid. Effect of apolipoprotein C-II.
    Vainio P; Virtanen JA; Kinnunen PK
    Biochim Biophys Acta; 1982 Jun; 711(3):386-90. PubMed ID: 7104374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the inhibition of microbial lipases by tetrahydrolipstatin.
    Haalck L; Spener F
    Methods Enzymol; 1997; 286():252-63. PubMed ID: 9309654
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of lipoprotein lipase activity by high density lipoprotein & apolipoproteins C, E & A in rhesus monkeys.
    Dahiya R; Sharma A; Ahlawat RS
    Indian J Med Res; 1990 Apr; 92():115-9. PubMed ID: 2370091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-terminal domain of apolipoprotein CII as both activator and competitive inhibitor of lipoprotein lipase.
    Cheng Q; Blackett P; Jackson KW; McConathy WJ; Wang CS
    Biochem J; 1990 Jul; 269(2):403-7. PubMed ID: 2386483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of purified bovine milk lipoprotein lipase by propranolol and other beta-adrenergic blockers in vitro.
    Kubo M; Hostetler KY
    Biochim Biophys Acta; 1987 Apr; 918(2):168-74. PubMed ID: 2881580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of product inhibition and mechanisms of lipoprotein lipase activation by apolipoprotein C-II.
    Posner I; DeSanctis J
    Biochemistry; 1987 Jun; 26(12):3711-7. PubMed ID: 3651406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new fluorometric method for measuring the action of C apolipoproteins on milk lipoprotein lipase.
    Lambert DA; Catapano AL; Smith LC; Sparrow JT; Gotto AM
    Clin Chim Acta; 1997 Aug; 264(1):75-90. PubMed ID: 9267705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The competitive inhibition of C-II dependent lipoprotein lipase activity by heparin.
    Posner I
    Acta Cient Venez; 1983; 34(2):118-23. PubMed ID: 6544540
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat.
    Blackett P; Tryggestad J; Krishnan S; Li S; Xu W; Alaupovic P; Quiroga C; Copeland K
    J Clin Lipidol; 2013; 7(2):132-9. PubMed ID: 23415432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of purified human postheparin lipoprotein lipase by beta-adrenergic blockers in vitro.
    Kihara S; Kubo M; Ikeda N; Yokoyama S; Matsuzawa Y; Tarui S; Yamamoto A; Hostetler KY
    Biochem Pharmacol; 1989 Feb; 38(3):407-11. PubMed ID: 2563651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orlistat inhibition of intestinal lipase acutely increases appetite and attenuates postprandial glucagon-like peptide-1-(7-36)-amide-1, cholecystokinin, and peptide YY concentrations.
    Ellrichmann M; Kapelle M; Ritter PR; Holst JJ; Herzig KH; Schmidt WE; Schmitz F; Meier JJ
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3995-8. PubMed ID: 18647814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orlistat response to missense mutations in lipoprotein lipase.
    Chen H; Jia J; Ni Z; Vastermark A; Wu B; Le Y; Jawad U
    Biotechnol Appl Biochem; 2017 Jul; 64(4):464-470. PubMed ID: 27097985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the lipase inhibitors, Triton WR-1339 and tetrahydrolipstatin, on the synthesis and secretion of lipids by rat hepatocytes.
    Hermier D; Hales P; Brindley DN
    FEBS Lett; 1991 Jul; 286(1-2):186-8. PubMed ID: 1864367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.